Memantine and exercise to protect thinking during chemo for breast cancer
Treatments studied
Part of Cancer, Mental health, Skin clinical trials.
This study tests whether a medicine called memantine combined with a structured exercise program can help protect your thinking and memory during chemotherapy for breast cancer. It may also help understand how these treatments work in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and at least 18 years old.
- You have been diagnosed with stage I, II, or III breast cancer.
- Your doctor has recommended chemotherapy as part of your treatment plan.
- You can sign up for this study before your third round of chemotherapy.
- You speak English.
- You do not have a severe memory problem, a recent heart attack, or a condition that prevents you from exercising safely.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a structured exercise program can help protect or improve thinking and memory in people with breast cancer while they are starting chemotherapy after surgery. It may help with “chemo brain” by targeting brain function during treatment.
This study tests a supervised computer-based mental exercise program to help reduce memory and thinking problems after chemotherapy. It is for people who finished chemo for early-stage breast cancer and still have bothersome mental fogginess.
This study tests whether taking a creatine supplement during chemotherapy can help protect your thinking and memory. It is for people with early-stage breast cancer who are about to receive chemotherapy.
This study checks how breast cancer affects memory and thinking before other treatments start. It may help doctors better understand cognitive changes and who is most at risk.
This study looks at memory, focus, and other thinking skills in women who finished breast cancer treatment. It aims to find ways to help with any mental difficulties after treatment.
This pilot study tests whether the drug riluzole can help prevent the thinking and memory problems (often called 'chemobrain') that some people experience during chemotherapy. If you are about to start a chemo regimen containing an anthracycline or platinum drug, you may be able to join.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.